Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,226 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06659458Recruiting
EGFR lung cancer gene study using advanced DNA sequencing
This trial uses long-read sequencing to study the EGFR gene in women with EGFR-positive lung cancer. It aims to learn more about the cancer's DNA to improve future treatments.
Baton Rouge, LouisianaAges 18–100 - NCT06758375RecruitingPhase 2
Low dose teclistamab for newly diagnosed multiple myeloma
This trial tests a lower dose of the drug teclistamab in people newly diagnosed with multiple myeloma. It aims to see if a lower dose is still effective and has fewer side effects.
Monterrey, Nuevo LeónAges 18 years+ - NCT06870903Recruiting
Comparing two lymph node removal methods in vaginal surgery for early endometrial cancer
This trial compares two ways of removing lymph nodes during a vaginal minimally invasive surgery for early-stage endometrial cancer. It aims to find which method is safer and more effective.
Diyarbakır, BaglarAges 18–85 - NCT06887114Recruiting
Lumbar back therapy for better walking and balance after stroke
This study tests a gentle, hands-on therapy called Mulligan Mobilization for the lower back. It may help improve walking, balance, and body awareness after a stroke.
AnkaraAges 30–65 - NCT06885411Recruiting
Hearing loss from metal-on-metal hip implants
This study looks at whether metal-on-metal hip replacements can affect hearing. It aims to understand if there is a link between these implants and hearing loss.
DelftAges Any age - NCT05527093Recruiting
Brain-scan study mapping social thinking changes in epilepsy
This study uses special thinking and brain-scanning tests to understand how “social thinking” may change in people with certain types of epilepsy. You might benefit by having a detailed evaluation during your planned pre-surgery workup.
Gif-sur-YvetteAges 18–65 - NCT06885476Recruiting
NK cell infusion for AML patients with minimal cancer left
This trial tests if giving special immune cells from a donor can clear leftover leukemia cells in patients who are in remission but still have traces of cancer after chemotherapy.
Bologna, BOAges 18 years+ - NCT06886425Recruiting
Study of how azacytidine works in blood cancers
This study looks at how certain enzymes in your body affect the way a drug called azacytidine works against blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The goal is to better understand who might benefit most from this treatment.
MarseilleAges 18 years+ - NCT06887101Recruiting
Stress and heart risks in peripheral artery disease
This study looks at how stress affects heart and blood vessel events in people with peripheral artery disease (PAD). It aims to help understand if stress plays a role in worsening PAD or causing related problems like heart attacks or strokes.
EssenAges 18 years+ - NCT06887907Recruiting
Studying megakaryocytes in sickle cell disease
This trial looks at the cells that help make platelets (megakaryocytes) in people with sickle cell disease. By comparing these cells when you are feeling well and during a pain crisis or chest syndrome, researchers hope to learn more about the condition and find better treatments.
Toulouse, FranceAges 18 years+ - NCT03711110Recruiting
Heart-protection plan for older people with certain cancers
This trial looks at strategies to help prevent heart and blood-vessel problems in people over 65 who have certain cancers. It may help by monitoring and treating heart risks early to lower the chance of future cardiovascular events.
Santiago de Compostela, A CoruñaAges 65 years+ - NCT03671044RecruitingPhase 3
Testing a nano-form of docetaxel for triple-negative breast cancer
This Phase 3 study tests whether a special form of docetaxel (a chemotherapy drug) works better and is safe for people with triple-negative breast cancer that has spread or grown locally. You may be eligible if your cancer is triple-negative and you have measurable disease that can be tracked on scans, along with adequate organ and heart function.
Columbus, GeorgiaAges 18–65 - NCT05644717RecruitingPhase 4
Testing erugliflozin for fatty liver and diabetes control
This trial studies whether erugliflozin can reduce liver fat and liver scarring (fibrosis) while also improving blood sugar in people with type 2 diabetes and fatty liver disease (NASH/NAFLD). It’s designed for people who haven’t used certain diabetes medicines like SGLT2 inhibitors or insulin before.
Peshawar, KPKAges 18–65 - NCT06539520Recruiting
Walking exercise for heart and lung health after stroke
This trial tests whether a supervised walking and exercise program can improve your heart and lung fitness and overall quality of life after a stroke. It is designed for people who are still affected by weakness on one side but can walk on their own.
GizaAges 55–65 - NCT06846970Recruiting
Hot spring therapy plus physical therapy for chronic back pain
This study tests whether adding hot spring therapy (balneotherapy) to a standard physical therapy program can improve pain and function for people with chronic nerve-related back pain. It may help if you have long-term sciatica-like pain and have not had recent hot spring treatments.
Afyonkarahisar, CentralAges 18–75 - NCT06706791RecruitingPhase 4
Empagliflozin for heart failure & diabetes: quality of life study
This trial tests whether a diabetes medicine called empagliflozin can improve the quality of life for people who have both chronic heart failure with a weak heart pump and type 2 diabetes. It compares the effects of adding empagliflozin to your current treatments.
Karachi, SindhAges 40–70 - NCT06889662Recruiting
Genetic testing study for arrhythmic myocarditis
This study tests whether looking at your genes can help doctors understand and treat arrhythmic myocarditis (a type of heart muscle inflammation that can cause irregular heartbeats). It may help find better treatments for people with this condition.
Milan, Italy/MilanAges 10–80 - NCT07278739Recruiting
Talking about your goals of care with your cancer team
This study tests an educational program to help patients with advanced cancer talk about their goals of care. The goal is to make sure your wishes are known and respected by your care team.
Little Rock, ArkansasAges 18 years+ - NCT07278089Recruiting
AF screening for people with heart changes on echo
This trial checks if people with certain heart conditions seen on an echo (like an enlarged heart or stiff heart muscle) have undetected atrial fibrillation (AF). It aims to find AF early so it can be treated to prevent strokes.
TaipeiAges 20 years+ - NCT07275931Recruiting
Digital support program for heart failure patients
Researchers in Sweden are testing a digital support program to help patients with heart failure manage their condition at home. If you qualify, you'll use a smartphone or computer-based program that may offer tips, tracking, and help from a care team.
Linköping, Östergötland CountyAges 18 years+ - NCT07273357Recruiting
CDK4/6 inhibitors for older breast cancer patients
This study looks at how well older breast cancer patients (70 years and older) do when treated with a type of drug called a CDK4/6 inhibitor along with hormone therapy after surgery. The goal is to use simple health checks to help doctors decide if this treatment is right for you.
GävleAges 70 years+ - NCT07276282RecruitingPhase 3
Ziltivekimab for heart attack patients with artery plaque
This trial tests a new drug called Ziltivekimab to see if it can reduce plaque buildup in the heart arteries after a heart attack. It may help prevent future heart problems by targeting inflammation.
BernAges 18 years+ - NCT07273877Enrolling by invitation
Blood pressure control with the Netrod RDN system
This study is for people with high blood pressure who are already using or planning to use the Netrod RDN system, a device that uses radiofrequency energy to treat the nerves around the kidneys. The study aims to see how well this system controls blood pressure in real life.
Beijing, Beijing MunicipalityAges Any age - NCT07274852RecruitingPhase 1
Study of a radioactive drug for advanced solid tumors
This trial tests a new radioactive drug (177Lu-BL-ARC001) for people with advanced lung, breast, head and neck, or other solid tumors that have not responded to standard treatments. It aims to see if the drug can target and shrink tumors while limiting side effects.
Chengdu, SichuanAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,226 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.